 Michaela Dolan
Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 7 | 2021 | 862 | 0.610 |
Why?
| | HIV Envelope Protein gp120 | 5 | 2018 | 60 | 0.550 |
Why?
| | Structural Homology, Protein | 3 | 2012 | 27 | 0.480 |
Why?
| | Computer Simulation | 6 | 2012 | 984 | 0.450 |
Why?
| | Protein Conformation | 7 | 2018 | 930 | 0.450 |
Why?
| | Models, Molecular | 14 | 2018 | 1586 | 0.440 |
Why?
| | Proteins | 2 | 2012 | 1012 | 0.430 |
Why?
| | Sequence Alignment | 4 | 2016 | 344 | 0.420 |
Why?
| | Algorithms | 2 | 2012 | 1695 | 0.390 |
Why?
| | env Gene Products, Human Immunodeficiency Virus | 2 | 2021 | 16 | 0.330 |
Why?
| | CD4 Antigens | 3 | 2018 | 141 | 0.300 |
Why?
| | Genome, Viral | 3 | 2018 | 141 | 0.290 |
Why?
| | Molecular Dynamics Simulation | 6 | 2017 | 237 | 0.280 |
Why?
| | Software | 2 | 2012 | 670 | 0.270 |
Why?
| | HIV Antibodies | 4 | 2021 | 62 | 0.260 |
Why?
| | Antibodies, Neutralizing | 4 | 2021 | 282 | 0.220 |
Why?
| | Viral Proteins | 3 | 2017 | 346 | 0.210 |
Why?
| | Amyloid | 2 | 2014 | 89 | 0.210 |
Why?
| | Nucleic Acid Conformation | 5 | 2013 | 720 | 0.210 |
Why?
| | Amino Acid Sequence | 9 | 2021 | 2143 | 0.200 |
Why?
| | Binding Sites | 7 | 2017 | 1308 | 0.200 |
Why?
| | Ebolavirus | 2 | 2013 | 35 | 0.190 |
Why?
| | Protein Binding | 7 | 2018 | 2222 | 0.190 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2001 | 544 | 0.190 |
Why?
| | RNA, Bacterial | 3 | 2001 | 186 | 0.180 |
Why?
| | Protein Stability | 2 | 2018 | 178 | 0.170 |
Why?
| | Peptide Fragments | 2 | 2016 | 707 | 0.170 |
Why?
| | Escherichia coli | 3 | 2001 | 815 | 0.170 |
Why?
| | Tyrosine | 3 | 2016 | 224 | 0.150 |
Why?
| | Protein Multimerization | 2 | 2017 | 193 | 0.150 |
Why?
| | Influenza A Virus, H3N2 Subtype | 1 | 2018 | 43 | 0.150 |
Why?
| | Metalloporphyrins | 1 | 1998 | 103 | 0.140 |
Why?
| | Leukemia Virus, Murine | 1 | 2017 | 18 | 0.140 |
Why?
| | Leukemia, Experimental | 1 | 2017 | 27 | 0.140 |
Why?
| | Host Specificity | 1 | 2017 | 26 | 0.140 |
Why?
| | Tumor Virus Infections | 1 | 2017 | 47 | 0.140 |
Why?
| | Molecular Sequence Data | 8 | 2016 | 2901 | 0.140 |
Why?
| | Retroviridae Infections | 1 | 2017 | 46 | 0.140 |
Why?
| | Antigen Presentation | 2 | 2016 | 216 | 0.140 |
Why?
| | Filoviridae Infections | 1 | 2016 | 4 | 0.130 |
Why?
| | Filoviridae | 1 | 2016 | 6 | 0.130 |
Why?
| | Protein Domains | 1 | 2018 | 290 | 0.130 |
Why?
| | RNA Viruses | 1 | 2017 | 40 | 0.130 |
Why?
| | Norwalk virus | 1 | 2016 | 1 | 0.130 |
Why?
| | Molecular Mimicry | 1 | 2016 | 40 | 0.130 |
Why?
| | Receptors, CCR5 | 1 | 2016 | 59 | 0.130 |
Why?
| | Single-Chain Antibodies | 1 | 2016 | 18 | 0.130 |
Why?
| | HLA-A2 Antigen | 1 | 2016 | 48 | 0.130 |
Why?
| | Genome, Human | 1 | 2018 | 422 | 0.120 |
Why?
| | Adaptation, Biological | 1 | 2016 | 56 | 0.120 |
Why?
| | RNA, Viral | 2 | 2013 | 651 | 0.120 |
Why?
| | Viral Vaccines | 1 | 2017 | 98 | 0.120 |
Why?
| | Immune Evasion | 2 | 2018 | 58 | 0.120 |
Why?
| | Capsid Proteins | 1 | 2016 | 94 | 0.120 |
Why?
| | Immunoglobulins | 1 | 2016 | 171 | 0.120 |
Why?
| | Filaricides | 1 | 2015 | 1 | 0.120 |
Why?
| | Brugia malayi | 1 | 2015 | 2 | 0.120 |
Why?
| | Host-Pathogen Interactions | 1 | 2018 | 367 | 0.120 |
Why?
| | PrPSc Proteins | 1 | 2014 | 9 | 0.120 |
Why?
| | Prion Diseases | 1 | 2014 | 16 | 0.120 |
Why?
| | Acyltransferases | 1 | 2014 | 56 | 0.110 |
Why?
| | Prions | 1 | 2014 | 48 | 0.110 |
Why?
| | Epitopes | 1 | 2016 | 479 | 0.110 |
Why?
| | RNA Editing | 1 | 2013 | 24 | 0.110 |
Why?
| | Antigens, Bacterial | 1 | 2014 | 129 | 0.110 |
Why?
| | Cytidine Deaminase | 2 | 2011 | 61 | 0.100 |
Why?
| | Base Sequence | 6 | 2017 | 2180 | 0.100 |
Why?
| | Codon | 2 | 2017 | 90 | 0.100 |
Why?
| | Receptors, Pattern Recognition | 1 | 2012 | 12 | 0.100 |
Why?
| | Virus Replication | 2 | 2017 | 477 | 0.100 |
Why?
| | Models, Chemical | 2 | 2008 | 268 | 0.100 |
Why?
| | Immunity, Innate | 1 | 2018 | 832 | 0.100 |
Why?
| | Lysine | 1 | 2014 | 297 | 0.100 |
Why?
| | H-2 Antigens | 1 | 2012 | 115 | 0.100 |
Why?
| | Sterol 14-Demethylase | 1 | 2011 | 1 | 0.100 |
Why?
| | Influenza, Human | 1 | 2018 | 626 | 0.100 |
Why?
| | Drug Resistance, Fungal | 1 | 2011 | 7 | 0.100 |
Why?
| | Antibodies, Viral | 1 | 2016 | 620 | 0.090 |
Why?
| | Cryptococcus neoformans | 1 | 2011 | 21 | 0.090 |
Why?
| | Cryptococcosis | 1 | 2011 | 27 | 0.090 |
Why?
| | Databases, Protein | 1 | 2012 | 86 | 0.090 |
Why?
| | DNA | 1 | 1998 | 1460 | 0.090 |
Why?
| | Cytosine Deaminase | 1 | 2011 | 16 | 0.090 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2011 | 56 | 0.090 |
Why?
| | Interleukin-13 Receptor alpha1 Subunit | 1 | 2011 | 3 | 0.090 |
Why?
| | Protein Structure, Tertiary | 5 | 2016 | 869 | 0.090 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2012 | 203 | 0.090 |
Why?
| | Fungal Proteins | 1 | 2011 | 134 | 0.090 |
Why?
| | Interleukin-13 Receptor alpha2 Subunit | 1 | 2011 | 6 | 0.090 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 2011 | 28 | 0.090 |
Why?
| | Viral Matrix Proteins | 1 | 2011 | 30 | 0.090 |
Why?
| | Antifungal Agents | 1 | 2011 | 137 | 0.090 |
Why?
| | Mycobacterium tuberculosis | 1 | 2014 | 317 | 0.090 |
Why?
| | Ribosomes | 3 | 2001 | 170 | 0.090 |
Why?
| | HIV Infections | 4 | 2021 | 2822 | 0.090 |
Why?
| | Animals | 14 | 2018 | 36915 | 0.090 |
Why?
| | RNA, Messenger | 2 | 2013 | 2837 | 0.080 |
Why?
| | Interferon-alpha | 1 | 2011 | 198 | 0.080 |
Why?
| | Peptides | 1 | 2016 | 981 | 0.080 |
Why?
| | Interleukin-13 | 1 | 2011 | 149 | 0.080 |
Why?
| | HEK293 Cells | 3 | 2018 | 734 | 0.080 |
Why?
| | Membrane Proteins | 1 | 2016 | 1167 | 0.080 |
Why?
| | Bacterial Proteins | 2 | 2014 | 889 | 0.080 |
Why?
| | Recombinant Proteins | 2 | 2014 | 1357 | 0.080 |
Why?
| | RNA Interference | 1 | 2011 | 463 | 0.080 |
Why?
| | Protein Kinase Inhibitors | 1 | 2015 | 919 | 0.080 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 620 | 0.070 |
Why?
| | Crystallography | 1 | 2008 | 27 | 0.070 |
Why?
| | Mice, Inbred BALB C | 3 | 2017 | 1271 | 0.070 |
Why?
| | Protein Structure, Quaternary | 2 | 2018 | 126 | 0.070 |
Why?
| | BRCA1 Protein | 1 | 2007 | 76 | 0.070 |
Why?
| | Mice | 8 | 2017 | 17775 | 0.070 |
Why?
| | Neutralization Tests | 2 | 2018 | 75 | 0.070 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2012 | 916 | 0.060 |
Why?
| | DNA Repair | 1 | 2007 | 229 | 0.060 |
Why?
| | Cell Line | 3 | 2017 | 2847 | 0.060 |
Why?
| | Disease Models, Animal | 1 | 2016 | 4281 | 0.060 |
Why?
| | Surface Plasmon Resonance | 2 | 2017 | 88 | 0.060 |
Why?
| | Mutagenesis | 2 | 2017 | 182 | 0.060 |
Why?
| | Base Pairing | 2 | 2004 | 62 | 0.060 |
Why?
| | Tombusviridae | 1 | 2004 | 1 | 0.060 |
Why?
| | Polymorphism, Genetic | 1 | 2007 | 652 | 0.060 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 1 | 2004 | 19 | 0.060 |
Why?
| | Water | 1 | 2008 | 464 | 0.060 |
Why?
| | Vero Cells | 2 | 2017 | 67 | 0.060 |
Why?
| | Polysaccharides | 2 | 2014 | 87 | 0.050 |
Why?
| | Humans | 18 | 2021 | 136899 | 0.050 |
Why?
| | Protein Structure, Secondary | 2 | 2014 | 373 | 0.050 |
Why?
| | Macrophages | 1 | 2011 | 1547 | 0.050 |
Why?
| | Transcription Factors | 1 | 2011 | 1715 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2014 | 387 | 0.050 |
Why?
| | Mutation | 3 | 2021 | 3948 | 0.050 |
Why?
| | Crystallography, X-Ray | 2 | 2012 | 474 | 0.040 |
Why?
| | RNA, Transfer, Met | 1 | 2000 | 6 | 0.040 |
Why?
| | Amino Acid Motifs | 1 | 2021 | 225 | 0.040 |
Why?
| | Peptide Initiation Factors | 1 | 2000 | 17 | 0.040 |
Why?
| | Structure-Activity Relationship | 2 | 2012 | 586 | 0.040 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2021 | 191 | 0.040 |
Why?
| | Evolution, Molecular | 2 | 2017 | 488 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2007 | 1502 | 0.040 |
Why?
| | Pyrimidines | 2 | 2015 | 472 | 0.040 |
Why?
| | Spectinomycin | 1 | 1999 | 2 | 0.040 |
Why?
| | Tetracycline | 1 | 1999 | 12 | 0.040 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 2 | 2016 | 340 | 0.040 |
Why?
| | Spectrophotometry, Atomic | 1 | 1998 | 13 | 0.040 |
Why?
| | Intercalating Agents | 1 | 1998 | 5 | 0.040 |
Why?
| | Neuraminidase | 1 | 2018 | 25 | 0.040 |
Why?
| | HIV Envelope Protein gp160 | 1 | 2018 | 5 | 0.040 |
Why?
| | HIV Antigens | 1 | 2018 | 17 | 0.040 |
Why?
| | Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2018 | 25 | 0.040 |
Why?
| | Cations | 1 | 1998 | 85 | 0.040 |
Why?
| | Circular Dichroism | 1 | 1998 | 151 | 0.040 |
Why?
| | Electron Spin Resonance Spectroscopy | 1 | 1998 | 94 | 0.040 |
Why?
| | Virus Internalization | 1 | 2018 | 47 | 0.040 |
Why?
| | AIDS Vaccines | 1 | 2018 | 52 | 0.040 |
Why?
| | Terminal Repeat Sequences | 1 | 2017 | 17 | 0.040 |
Why?
| | Sequence Homology | 1 | 2017 | 40 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2018 | 401 | 0.030 |
Why?
| | Receptors, Virus | 1 | 2017 | 83 | 0.030 |
Why?
| | Antibodies, Monoclonal | 2 | 2016 | 1417 | 0.030 |
Why?
| | Bronchi | 1 | 2018 | 259 | 0.030 |
Why?
| | Rabbits | 1 | 2018 | 792 | 0.030 |
Why?
| | RNA Splicing | 1 | 2018 | 268 | 0.030 |
Why?
| | Vaccines, Synthetic | 1 | 2017 | 126 | 0.030 |
Why?
| | Calicivirus, Feline | 1 | 2016 | 2 | 0.030 |
Why?
| | Open Reading Frames | 1 | 2017 | 120 | 0.030 |
Why?
| | Vaccines, Attenuated | 1 | 2017 | 129 | 0.030 |
Why?
| | Guinea Pigs | 1 | 2016 | 162 | 0.030 |
Why?
| | Epitope Mapping | 1 | 2016 | 60 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2016 | 116 | 0.030 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2017 | 75 | 0.030 |
Why?
| | Cryoelectron Microscopy | 1 | 2017 | 184 | 0.030 |
Why?
| | Cricetinae | 1 | 2016 | 288 | 0.030 |
Why?
| | Cattle | 1 | 1998 | 982 | 0.030 |
Why?
| | Immunization | 1 | 2018 | 414 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1998 | 616 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 451 | 0.030 |
Why?
| | Seasons | 1 | 2018 | 540 | 0.030 |
Why?
| | Capsid | 1 | 2016 | 93 | 0.030 |
Why?
| | Virulence | 1 | 2016 | 266 | 0.030 |
Why?
| | Mesocricetus | 1 | 2014 | 39 | 0.030 |
Why?
| | Inhibitory Concentration 50 | 1 | 2015 | 90 | 0.030 |
Why?
| | Polyelectrolytes | 1 | 2014 | 16 | 0.030 |
Why?
| | Imatinib Mesylate | 1 | 2015 | 79 | 0.030 |
Why?
| | Dasatinib | 1 | 2015 | 54 | 0.030 |
Why?
| | Cord Factors | 1 | 2014 | 1 | 0.030 |
Why?
| | Carbon-13 Magnetic Resonance Spectroscopy | 1 | 2014 | 3 | 0.030 |
Why?
| | Microscopy, Electron, Scanning Transmission | 1 | 2014 | 4 | 0.030 |
Why?
| | Carbohydrate Sequence | 1 | 2014 | 27 | 0.030 |
Why?
| | Galactans | 1 | 2014 | 4 | 0.030 |
Why?
| | Static Electricity | 1 | 2014 | 120 | 0.030 |
Why?
| | Thiazoles | 1 | 2015 | 122 | 0.030 |
Why?
| | Cell Wall | 1 | 2014 | 60 | 0.030 |
Why?
| | Biocatalysis | 1 | 2014 | 69 | 0.030 |
Why?
| | Larva | 1 | 2015 | 221 | 0.030 |
Why?
| | Disulfides | 1 | 2014 | 107 | 0.030 |
Why?
| | Benzamides | 1 | 2015 | 218 | 0.030 |
Why?
| | RNA | 1 | 2001 | 924 | 0.030 |
Why?
| | Drosophila melanogaster | 1 | 2016 | 228 | 0.030 |
Why?
| | Proteolysis | 1 | 2014 | 179 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2014 | 385 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2014 | 227 | 0.030 |
Why?
| | Kinetics | 1 | 2017 | 1679 | 0.030 |
Why?
| | Protein Folding | 1 | 2014 | 282 | 0.030 |
Why?
| | Histocompatibility Antigen H-2D | 1 | 2012 | 21 | 0.020 |
Why?
| | Piperazines | 1 | 2015 | 349 | 0.020 |
Why?
| | beta 2-Microglobulin | 1 | 2012 | 50 | 0.020 |
Why?
| | 14-alpha Demethylase Inhibitors | 1 | 2011 | 1 | 0.020 |
Why?
| | Itraconazole | 1 | 2011 | 6 | 0.020 |
Why?
| | Fluconazole | 1 | 2011 | 18 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2018 | 1097 | 0.020 |
Why?
| | Voriconazole | 1 | 2011 | 20 | 0.020 |
Why?
| | APOBEC Deaminases | 1 | 2011 | 6 | 0.020 |
Why?
| | Phenylalanine | 1 | 2011 | 68 | 0.020 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2011 | 34 | 0.020 |
Why?
| | Calmodulin | 1 | 2011 | 76 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1769 | 0.020 |
Why?
| | Blotting, Western | 1 | 2014 | 1227 | 0.020 |
Why?
| | Protein Interaction Mapping | 1 | 2011 | 109 | 0.020 |
Why?
| | Gene Expression | 1 | 2016 | 1505 | 0.020 |
Why?
| | Protein Array Analysis | 1 | 2011 | 57 | 0.020 |
Why?
| | APOBEC-3G Deaminase | 1 | 2010 | 6 | 0.020 |
Why?
| | Polymers | 1 | 2014 | 495 | 0.020 |
Why?
| | Triazoles | 1 | 2011 | 151 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2010 | 65 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2010 | 155 | 0.020 |
Why?
| | Microbial Sensitivity Tests | 1 | 2011 | 362 | 0.020 |
Why?
| | Animals, Wild | 1 | 2010 | 58 | 0.020 |
Why?
| | Ligands | 1 | 2012 | 665 | 0.020 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2011 | 151 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2014 | 1185 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2011 | 338 | 0.020 |
Why?
| | Anti-HIV Agents | 1 | 2016 | 773 | 0.020 |
Why?
| | Virulence Factors | 1 | 2011 | 167 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 1999 | 1790 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2011 | 664 | 0.020 |
Why?
| | Selection, Genetic | 1 | 2010 | 262 | 0.020 |
Why?
| | Anti-Retroviral Agents | 1 | 2010 | 235 | 0.020 |
Why?
| | X-ray Repair Cross Complementing Protein 1 | 1 | 2007 | 13 | 0.020 |
Why?
| | Porosity | 1 | 2008 | 99 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2008 | 152 | 0.020 |
Why?
| | NF-kappa B | 1 | 2011 | 685 | 0.020 |
Why?
| | Survival Rate | 1 | 2011 | 1972 | 0.020 |
Why?
| | Ultraviolet Rays | 2 | 2000 | 389 | 0.020 |
Why?
| | Genotype | 1 | 2011 | 1906 | 0.020 |
Why?
| | Transcription, Genetic | 2 | 2004 | 1458 | 0.020 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2004 | 93 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 2004 | 227 | 0.010 |
Why?
| | Female | 3 | 2018 | 72703 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2615 | 0.010 |
Why?
| | Alkalies | 1 | 2000 | 6 | 0.010 |
Why?
| | Prokaryotic Initiation Factor-3 | 1 | 2000 | 6 | 0.010 |
Why?
| | Anticodon | 1 | 2000 | 24 | 0.010 |
Why?
| | Ribosomal Proteins | 1 | 2000 | 82 | 0.010 |
Why?
| | Hydrolysis | 1 | 2000 | 191 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2004 | 1255 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2010 | 5766 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2007 | 2416 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 346 | 0.010 |
Why?
| | Signal Transduction | 1 | 2011 | 5077 | 0.010 |
Why?
| | RNA-Binding Proteins | 1 | 2000 | 424 | 0.010 |
Why?
| | Male | 1 | 2015 | 67308 | 0.000 |
Why?
|
|
Dolan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|